Genprex, Inc.
Genprex, Inc. (GNPX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gnpx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Genprex, Inc. (GNPX) measures how much investors pay for each dollar of the company's trailing earnings. GNPX's current PE ratio of N/A is calculated by dividing its stock price of $0.67 by its TTM earnings per share of -$2.41.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Genprex, Inc.You GNPX | $1M | N/A | — | -$2.41 |
 Biodexa Pharmaceuticals Plc BDRX | $1M | N/A | — | -$113.82 |
 BioVie Inc. BIVI | $13M | N/A | — | -$11.87 |
 CERo Therapeutics Holdings, Inc. CERO | $0M | N/A | — | -$4.71 |
 Chemomab Therapeutics Ltd. CMMB | $11M | N/A | — | -$1.41 |
 CNS Pharmaceuticals, Inc. CNSP | $3M | N/A | — | -$35.75 |
 GRI Bio, Inc. GRI | $0M | N/A | — | -$121.80 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-17.40 | — | |
2024-12-31 FY2024 | — | $-263.50 | — | |
2023-12-31 FY2023 | — | $-1128.77 | — | |
2022-12-31 FY2022 | — | $-990.84 | — | |
2021-12-31 FY2021 | — | $-877.87 | — | |
2020-12-31 FY2020 | — | $-1010.29 | — | |
2019-12-31 FY2019 | — | $-1331.85 | — | |
2018-12-31 FY2018 | — | $-1798.31 | — | |
2017-12-31 FY2017 | — | $-577.38 | — | |
2016-12-31 FY2016 | — | $-765.21 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Genprex, Inc. (GNPX) measures how much investors pay for each dollar of the company's trailing earnings. GNPX's current PE ratio of N/A is calculated by dividing its stock price of $0.67 by its TTM earnings per share of -$2.41.
Frequently asked questions
GNPX pe ratio · 6 questionsGNPX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.67 and TTM EPS of -$2.41. Data sourced from Financial Modeling Prep via GNPX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Genprex, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08